Stay updated with the latest developments at Curebase in a letter from our CEO.
Explore the unique challenges of pediatric studies and enhance your clinical trials with ePRO and eConsent solutions.
Discover how Walgreens’ collaboration with Curebase and Freenome will enhance accessibility in cancer research.
See why Curebase is chosen for the top 6% of Y Combinators' list of private companies.
Curebase plans to expand platforms and enhance clinical research capabilities with $40M funding from Gilead.
Learn why Curebase raised $40M to decentralize clinical trials and how we will bridge the gap in accessibility, consistency, and integrity.